Innovation Pharmaceuticals Inc (IPIX)

[Lemoncat]

Why does he not reconnect with Don Seiffert, managing editor of the Boston Business Journal, with whom he's corresponded with a few times before. Pick up the phone and get the word out, Bain Capital has an office in Boston, along with many others. He appears to prefer to share company info with retail investors only.

It's almost impossible to pitch a $0.11 OTC biotech with a few months of expenses (if that) in the bank. Each successive capital deal in the past year has been markedly worse than the last. A pharma development deal is the only way we will get a reasonable shake.